UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)             November 30, 2005


                           ON THE GO HEALTHCARE, INC.
             (Exact name of registrant as specified in its charter)

    DELAWARE                      333-61538                 98-0231687
 - ---------------             --------------------    -------------------
 (State or Other                 (Commission          (IRS Employer
 Jurisdiction of                 File Number)           Identification
  Incorporation)                                                   No.)

                          85 Corstate Avenue, Unit #1
                               Concord, Ontario
                                Canada L4K 4Y2
               ---------------------------------------------------
               (Address of principal executive offices) (Zip Code)


      Registrant's telephone number, including area code:  (905) 760-2987

 Check the appropriate box below if the Form 8-K filing is intended to
 simultaneously satisfy the filing obligation of the registrant under any of
 the following provisions (see General Instruction A.2. below):

 [ ] Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)
 [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)
 [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))
 [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Item 1.01  Entry into a Material Definitive Agreement.
Item 2.03  Creation of a Direct Financial Obligation or an Obligation under an
           Off-Balance Sheet Arrangement of a Registrant.

On November 30, 2005, we entered into a Promissory Note with Dutchess Private
Equities Fund, L.P. and Dutchess Private Equities Fund, II, L.P.  The principal
amount of the Note is $800,000 and it carries no interest.  The Note has a
discount of $160,000 and we will pay an additional $40,000 in fees.   Pursuant
to the terms of the Note, we will make payments in the amount of the greater
of $66,666.66 or 50% of each Put, as described in our Investment Agreement
with Dutchess, until the face amount is paid in full, minus any fees due.
Payments will be due on the third calendar day of each month.  The holder
has the right to convert the Note into shares of Common Stock any time
after the Closing Date.  The Note is subject to automatic conversion on
November 30, 2006.

<PAGE>

The description of the transaction contained herein is qualified in its
entirety by reference to the Promissory Note filed as Exhibit 4.1 and
incorporated herein by reference.  Additionally, the description of the
Put transaction contained herein is qualified in its entirety by reference
to the Investment Agreement between the Company and Dutchess Private
Equities Fund, L.P., dated February 27, 2004 (included as Exhibit 10.2 to
the Form SB-2 filed February 27,2004, and incorporated herein by reference).


This  report  may  contain  forward-looking  statements  that  involve risks
and uncertainties, including, without limitation, statements  concerning
our  business  and possible or assumed future results of operations.  We
generally  use  words  such  as  "believe,"  "may," "could," "will,"
"intend,"  "expect,"  "anticipate,"  "plan," and similar expressions to
identify  forward-looking  statements.  You should not place undue reliance
on these forward-looking statements.  Our actual results could differ
materially from those anticipated in the  forward-looking  statements  for
many  reasons  including:  our ability to continue  as  a  going  concern,
adverse  economic changes affecting markets we serve;  competition  in  our
markets  and industry segments; our timing and the profitability  of
entering  new  markets; greater than expected costs, customer acceptance  of
our  products  or difficulties related to our integration of the businesses
we may acquire; and other risks and uncertainties as may be detailed from
time  to  time  in  our  public announcements and SEC filings. Although we
believe  the  expectations  reflected  in  the  forward-looking  statements
are reasonable,  they  relate  only to events as of the date on which the
statements are  made,  and  our  future  results,  levels  of  activity,
performance  or achievements may not meet these expectations.  We do not
intend to update any of the  forward-looking statements after the date of
this document to conform these statements  to  actual  results  or  to
changes  in our expectations, except as required  by  law.


Item  9.01  Financial  Statements  and  Exhibits.

(c)  Exhibits:

4.1     Promissory Note between the Company and Dutchess Private Equities
        Fund, L.P. and Dutchess Private Equities Fund, II, L.P., dated
        November 30, 2005 (filed herewith).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                   ON THE GO HEALTHCARE, INC.
                                  (Registrant)
Date    December 5, 2005

                                  /s/ Stuart Turk
                                  ------------------------------------
                                  Print Name:  Stuart Turk
                                  Title:  President and Chief Executive Officer

<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "nov05_term8k.txt", "description": "NOV 30 2005 PROMISSORY NOTE 8K", "secsgml_size_bytes": 5794}]
{"company-data": {"conformed-name": "ON THE GO HEALTHCARE INC", "cik": "0001126302", "assigned-sic": "5045", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "0731"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-61538", "film-number": "051244271"}, "business-address": {"street1": "85 CORSTATE AVENUE UNIT 1", "city": "CONCORD ONT. CANADA", "state": "A6", "zip": "L4K 4Y2", "phone": "9057602987"}}
UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)             November 30, 2005

                           ON THE GO HEALTHCARE, INC.
             (Exact name of registrant as specified in its charter)

    DELAWARE                      333-61538                 98-0231687
 - ---------------             --------------------    -------------------
 (State or Other                 (Commission          (IRS Employer
 Jurisdiction of                 File Number)           Identification
  Incorporation)                                                   No.)

                          85 Corstate Avenue, Unit #1
                               Concord, Ontario
                                Canada L4K 4Y2
               ---------------------------------------------------
               (Address of principal executive offices) (Zip Code)

      Registrant's telephone number, including area code:  (905) 760-2987

 Check the appropriate box below if the Form 8-K filing is intended to
 simultaneously satisfy the filing obligation of the registrant under any of
 the following provisions (see General Instruction A.2. below):

 [ ] Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)
 [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)
 [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))
 [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Item 1.01  Entry into a Material Definitive Agreement.
Item 2.03  Creation of a Direct Financial Obligation or an Obligation under an
           Off-Balance Sheet Arrangement of a Registrant.

On November 30, 2005, we entered into a Promissory Note with Dutchess Private
Equities Fund, L.P. and Dutchess Private Equities Fund, II, L.P.  The principal
amount of the Note is $800,000 and it carries no interest.  The Note has a
discount of $160,000 and we will pay an additional $40,000 in fees.   Pursuant
to the terms of the Note, we will make payments in the amount of the greater
of $66,666.66 or 50% of each Put, as described in our Investment Agreement
with Dutchess, until the face amount is paid in full, minus any fees due.
Payments will be due on the third calendar day of each month.  The holder
has the right to convert the Note into shares of Common Stock any time
after the Closing Date.  The Note is subject to automatic conversion on
November 30, 2006.
The description of the transaction contained herein is qualified in its
entirety by reference to the Promissory Note filed as Exhibit 4.1 and
incorporated herein by reference.  Additionally, the description of the
Put transaction contained herein is qualified in its entirety by reference
to the Investment Agreement between the Company and Dutchess Private
Equities Fund, L.P., dated February 27, 2004 (included as Exhibit 10.2 to
the Form SB-2 filed February 27,2004, and incorporated herein by reference).

This  report  may  contain  forward-looking  statements  that  involve risks
and uncertainties, including, without limitation, statements  concerning
our  business  and possible or assumed future results of operations.  We
generally  use  words  such  as  "believe,"  "may," "could," "will,"
"intend,"  "expect,"  "anticipate,"  "plan," and similar expressions to
identify  forward-looking  statements.  You should not place undue reliance
on these forward-looking statements.  Our actual results could differ
materially from those anticipated in the  forward-looking  statements  for
many  reasons  including:  our ability to continue  as  a  going  concern,
adverse  economic changes affecting markets we serve;  competition  in  our
markets  and industry segments; our timing and the profitability  of
entering  new  markets; greater than expected costs, customer acceptance  of
our  products  or difficulties related to our integration of the businesses
we may acquire; and other risks and uncertainties as may be detailed from
time  to  time  in  our  public announcements and SEC filings. Although we
believe  the  expectations  reflected  in  the  forward-looking  statements
are reasonable,  they  relate  only to events as of the date on which the
statements are  made,  and  our  future  results,  levels  of  activity,
performance  or achievements may not meet these expectations.  We do not
intend to update any of the  forward-looking statements after the date of
this document to conform these statements  to  actual  results  or  to
changes  in our expectations, except as required  by  law.

Item  9.01  Financial  Statements  and  Exhibits.

(c)  Exhibits:

4.1     Promissory Note between the Company and Dutchess Private Equities
        Fund, L.P. and Dutchess Private Equities Fund, II, L.P., dated
        November 30, 2005 (filed herewith).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                   ON THE GO HEALTHCARE, INC.
                                  (Registrant)
Date    December 5, 2005

                                  /s/ Stuart Turk
                                  ------------------------------------
                                  Print Name:  Stuart Turk
                                  Title:  President and Chief Executive Officer